PE000665
Jump to navigation
Jump to search
| Name | K.ELHHLQEQN[H5N4S2]VSNAFLDKGEFYIGSK.Y |
|---|---|
| Sequence | ELHHLQEQNVSNAFLDKGEFYIGSK |
| Glycans(s) | H5N4S2 (N9) |
| Mod(s) | |
| Molecular Weight | 5125.208 |
| Norm. RT | 60.852 |
| Protein | CP (P00450) |
Samples
DDA Transition Groups
| Exp. R.T. | Peak R.T. | Norm. R.T. | Prec. m/z | Prec. z | Inst. | Sample | Transitions | |
|---|---|---|---|---|---|---|---|---|
| TG001487 | 36.086 | 36.636 | 61.392 | 1,277.807 | 4 | Orbitrap | Human Serum | 13 |
| TG003782 | 40.145 | 40.036 | 62.197 | 1,022.447 | 5 | Orbitrap | Human Serum | 10 |
| TG006616 | 36.217 | 36.287 | 58.526 | 1,703.407 | 3 | Orbitrap | Human Serum | 6 |
| TG005397 | 54.822 | 54.674 | 62.104 | 1,277.807 | 4 | Orbitrap | Human Serum | 11 |
| TG004881 | 40.212 | 40.176 | 54.721 | 1,022.447 | 5 | Orbitrap | Human Serum | 9 |
| TG005330 | 54.110 | 54.107 | 60.311 | 1,277.807 | 4 | Orbitrap | Human Serum | 9 |
DIA Transition Groups
| Exp. R.T. | Peak R.T. | Norm. R.T. | Prec. m/z | Prec. z | Inst. | Sample | Intensity | |
|---|---|---|---|---|---|---|---|---|
| TG008324 | 34.117 | 34.117 | 71.447 | 1,022.447 | 5 | TripleTOF | Human Serum | 392,804 |
| TG008631 | 34.235 | 34.235 | 70.199 | 1,022.447 | 5 | TripleTOF | Human Serum | 386,957 |
| TG008031 | 33.308 | 33.308 | 68.768 | 1,022.447 | 5 | TripleTOF | Human Serum | 321,984 |
| TG008925 | 33.402 | 33.402 | 71.372 | 1,022.447 | 5 | TripleTOF | Human Serum | 311,327 |
| TG009249 | 34.600 | 34.600 | 74.169 | 1,022.447 | 5 | TripleTOF | Human Serum | 255,025 |
| TG008242 | 33.298 | 33.298 | 68.728 | 1,277.807 | 4 | TripleTOF | Human Serum | 102,789 |
| TG010422 | 34.432 | 34.432 | 73.563 | 1,022.447 | 5 | TripleTOF | Human Serum | 91,843.6 |
| TG009554 | 33.162 | 33.162 | 67.548 | 1,022.447 | 5 | TripleTOF | Human Serum | 91,757.2 |
| TG009981 | 33.343 | 33.343 | 69.180 | 1,022.447 | 5 | TripleTOF | Human Serum | 78,485 |